Recruiting
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
NCT03975231
- Conditions
- BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Carcinoma, +5 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Univ of Texas-M.D. Anderson Cancer Center Houston, Texas, United States